<DOC>
	<DOCNO>NCT02613000</DOCNO>
	<brief_summary>Importance gastrointestinal ( GI ) function critically ill patient recognize , validate clinical tool monitor GI dysfunction part multiple organ dysfunction syndrome ( MODS ) . The general aim current project develop five grade score ( 0-4 point ) assessment GI function similar SOFA sub-scores use assessment organ system . 500 consecutive adult patient admit intensive care unit monitor gastrointestinal symptom , intra-abdominal pressure ( IAP ) acute gastrointestinal injury ( AGI ) grade [ 1 ] . In 200 patient , plasma urinary level possible biochemical marker intestinal injury assess . Objectives : - To determine prognostic value gastrointestinal symptom alone combination intra-abdominal pressure ( IAP ) , acute gastro-intestinal injury ( AGI ) grade predict ICU- , 28 day 90 day mortality adult intensive care patient ( Part A study ) - To describe blood urine level biochemical marker intestinal injury general cohort intensive care patient ( Part B study ) . - To compare prognostic value intestinal-specific plasma parameter ( IFABP , citrulline , ILBP , D-lactate ) gastrointestinal symptom , AGI grade , SOFA score predict ICU- , 28 day 90 day mortality adult intensive care patient ( Part B study ) Study design : prospective , observational , multicenter study Patient population : All consecutive adult critically ill patient ( 25 50 patient study site , 500 patient total ) need intensive care admission maximum 4 week study period . Duration study : individual patient 7 day follow-up 90 day Primary study outcome : 28 90 day all-cause mortality Secondary outcome : ICU hospital mortality , ICU length stay , hospital length stay , duration mechanical ventilation , multiple organ failure cause mortality , plasma urinary level intestinal fatty-acid binding protein ( I-FABP ) , citrulline , ileal lipid binding protein ( ILBP ) , D-lactate general cohort intensive care patient .</brief_summary>
	<brief_title>Intestinal-Specific Organ Function Assessment ( iSOFA Study )</brief_title>
	<detailed_description>Objectives 1 . To determine prognostic value gastrointestinal symptom alone combination intra-abdominal pressure ( IAP ) , acute gastro-intestinal injury ( AGI ) grade predict ICU- , 28 day 90 day mortality adult intensive care patient . 2 . To describe blood urine level intestinal-specific plasma parameter ( I-FABP , citrulline , ILBP , D-lactate ) general cohort intensive care patient . 3 . To compare prognostic value intestinal-specific plasma parameter ( I-FABP , citrulline , ILBP , D-lactate ) gastrointestinal symptom , AGI grade , SOFA score predict ICU- , 28 day 90 day mortality adult intensive care patient . Hypothesis 1 . GI symptom , alone combination IAP , AGI grade define WGAP statement improve predictive capability SOFA score critically ill patient . 2 . Intestinal-specific plasma urinary marker good excellent predictor outcome critically ill patient . 3 . Best prediction achieve combination GI symptom , IAP plasma marker . 4 . A clinical score develop base data study combine exist SOFA score thereby predictive value SOFA score improve . To test hypothesis , study two part : Part A . Clinical data routine laboratory parameter 500 consecutive patient collect 7 day ICU admission . Standard treatment implement ; additional intervention solely study perform . Waived consent expect . Part B . Blood urinary sample intestinal-specific laboratory marker draw daily 200 patient enrolled Part A , analyze addition standard clinical laboratory data . First blood sample take admission intensive care unit . Informed consent therefore obtain patient next kin blood urine sampling ( delayed consent ) . Research question Part A . 1 . What predictive capability gastrointestinal symptom , IAP AGI grade intensive care patient ? 2 . Does use AGI grade new AGI score base GI symptom alone combination IAP improve predictive capability SOFA score intensive care patient ? Part B . 3 . What relationship intestinal-specific marker disease severity organ dysfunction , describe APACHE SOFA score ? 4 . What predictive value intestinal-specific marker predict ICU- , 28 day 90 day all-cause mortality , ICU hospital length stay , duration mechanical ventilation ? 5 . Is correlation intestinal-specific marker gastrointestinal sign symptom ? 6 . Is predictive value intestinal specific marker higher compare GI symptom , IAP AGI grade predict ICU- , 28 day 90 day all-cause mortality , ICU hospital length stay , duration mechanical ventilation ? 7 . Does addition intestinal-specific plasma urinary marker increase predictive value SOFA score predict outcome ? 8 . Is combination intestinal-specific marker GI symptom , IAP AGI grade well predict outcome compare two individual item ? 9 . What comparisons best marker combination marker ? Methods/design 1 . Study design , set patient population This prospective multicenter cohort study 500 consecutive adult patient admit intensive care unit monitor gastrointestinal symptom , IAP AGI grade . Of 500 patient , 200 patient include part B . All consecutive adult critically ill patient ( 25 50 patient study site ) need intensive care admission maximum 6 week . The study consist three phase : 1 . Screening assessment , documentation admission parameter ; 2 . Study period 7 day individual patient ; 3 . Follow-up period 90 day . 2 . Study site duration study The study conduct ICUs university teach hospital general ( non-academic ) hospital . 20 ICUs different country invite expected participate , site expect enrol 25 50 patient maximum period 6 week . For individual patient study period 7 day till ICU discharge follow-up 90 day .</detailed_description>
	<mesh_term>Critical Illness</mesh_term>
	<mesh_term>Multiple Organ Failure</mesh_term>
	<criteria>Part A Inclusion criterion Admission ICU study period ( patient already ICU time study start include ) Age least 18 year Exclusion criterion Age &lt; 18 year Restriction care admission ( i.e limitation intensive care measure ) Readmission 7 day initial admission ICU Part B Inclusion criterion Admission ICU study period ( patient already ICU time study start include ) Age least 18 year Signed informed consent patient next kin legal representative blood sampling . Exclusion criterion Age &lt; 18 year Restriction care admission ( i.e limitation intensive care measure ) Readmission 7 day initial admission ICU Absence sign inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>